Biotechnology & Life Sciences Global On demand · 24-48h

Global Soil Microbial DNA Testing Service Market Strategic Research Report

Global Soil Microbial DNA Testing Service Market Strategic R…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Soil Microbial DNA Testing Service Market
$8.8B2025
9.3%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Microbial Community Profiling, Metagenomic Sequencing, Targeted Quantitative Detection, Microbial Source Tracking Analysis

By Application: Precision Agriculture, Environmental Monitoring, Ecological Restoration, Biotechnology Research, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Illumina, Inc. (NASDAQ: ILMN, California USA), SGS (SIX: SGSN, Geneva Switzerland), Thermo Fisher Scientific Inc. (NYSE: TMO, Massachusetts USA), Eurofins Scientific SE (Euronext: ERF, Luxembourg), Agilent Technologies, Inc. (NYSE: A, California USA), Zymo Research Corp. (Unlisted, California USA), Microsynth AG (Unlisted, Balgach Switzerland), CD Genomics (Unlisted, New York USA), Element Biosciences, Inc. (Unlisted, California USA), BaseClear B.V. (Unlisted, Leiden Netherlands), Molecular Research LP (MR DNA) (Unlisted, Texas USA), Metagen (Unlisted, Gatton Australia), Centre Testing International Group (SZSE: 300012, Shenzhen China), Novogene Co., Ltd. (SSE: 688315, Beijing China), Berry Genomics Co., Ltd. (SZSE: 000710, Beijing China), BGI Group (Unlisted, Shenzhen China), Beijing Biomarker Technologies Co., Ltd. (Unlisted, Beijing China), Guangzhou Magigene Biotechnology Co., Ltd. (Unlisted, Guangzhou China), Personal Biotechnology Co., Ltd. (Unlisted, Shanghai China)

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 126 pages
Market size 2025
$8.8B
Billion USD
Forecast CAGR
9.3%
2025-2032
Forecast 2032
$16.4B
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

نظرة عامة

Scope of the Report

The global Soil Microbial DNA Testing Service market size is predicted to grow from US$ 8,804 million in 2025 to US$ 16,350 million in 2032; it is expected to grow at a CAGR of 9.3% from 2026 to 2032.

Soil microbial DNA testing service utilizes high-throughput sequencing and other molecular biology technologie to directly extract and analyze the genetic material (DNA) of microorganisms (bacteria, fungi, archaea, etc.) from soil. This allows for comprehensive identification of microbial community composition, diversity, and functional genes without the need for culturing. Its core function is to transform the soil "black box" into visualized data, solving key problems that traditional methods struggle to assess, such as soil microbial health status, pathogen latent risk, and the impact of fertilization and pesticide application on microbial communities. This provides a scientific basis for decision-making in precision agriculture, soil remediation, and ecological research. The upstream sector comprises the supply of technology, equipment, and consumables, including sequencing instrument manufacturers, laboratory consumable suppliers, and bioinformatics analysis software development companies. The downstream sector directly serves end-user markets, primarily including: 1. Agriculture (large farms, organic plantations, for guiding fertilization and disease control); 2. Research institutions (universities, research institutes, environmental protection departments, for basic research and environmental monitoring); 3. Ecological restoration and consulting companies (for evaluating pollution control effectiveness and land reclamation plans). In 2025, the average price per sample for soil microbial DNA testing services was approximately $55, with a gross profit margin of approximately 55%.

Global key Soil Microbial DNA Testing Service players cover Illumina, Inc. (NASDAQ: ILMN, California USA), SGS (SIX: SGSN, Geneva Switzerland), Thermo Fisher Scientific Inc. (NYSE: TMO, Massachusetts USA), Eurofins Scientific SE (Euronext: ERF, Luxembourg), Agilent Technologies, Inc. (NYSE: A, California USA), etc.

This report presents a comprehensive overview of the global Soil Microbial DNA Testing Service market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Microbial Community Profiling
  • Metagenomic Sequencing
  • Targeted Quantitative Detection
  • Microbial Source Tracking Analysis

Segment by Technical Path

  • Amplicon Sequencing
  • Shotgun Metagenomic Sequencing
  • Metatranscriptomic Sequencing

Segment by Application

  • Precision Agriculture
  • Environmental Monitoring
  • Ecological Restoration
  • Biotechnology Research
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Soil Microbial DNA Testing Service market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Precision Agriculture, Environmental Monitoring, Ecological Restoration evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Soil Microbial DNA Testing Service Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 9.3%
Regional growth momentum
Market share by segment
Key metrics
Base value
$8.8B
2025
Forecast
$16.4B
2032
CAGR
9.3%
2025–2032
Regions
5
global
Key companies
IlluminaInc. (NASDAQ: ILMNCalifornia USA)SGS (SIX: SGSNGeneva Switzerland)Thermo Fisher Scientific Inc. (NYSE: TMOMassachusetts USA)Eurofins Scientific SE (Euronext: ERF
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Microbial Community ProfilingMetagenomic SequencingTargeted Quantitative DetectionMicrobial Source Tracking Analysis
By Application
Precision AgricultureEnvironmental MonitoringEcological RestorationBiotechnology ResearchOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Microbial Community Profiling
  • 3.1.3 Metagenomic Sequencing
  • 3.1.4 Targeted Quantitative Detection
  • 3.1.5 Microbial Source Tracking Analysis
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Precision Agriculture
  • 4.1.3 Environmental Monitoring
  • 4.1.4 Ecological Restoration
  • 4.1.5 Biotechnology Research
  • 4.1.6 Other
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Illumina, Inc. (NASDAQ: ILMN, California USA)
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 SGS (SIX: SGSN, Geneva Switzerland)
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Thermo Fisher Scientific Inc. (NYSE: TMO, Massachusetts USA)
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Eurofins Scientific SE (Euronext: ERF, Luxembourg)
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Agilent Technologies, Inc. (NYSE: A, California USA)
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Zymo Research Corp. (Unlisted, California USA)
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Microsynth AG (Unlisted, Balgach Switzerland)
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 CD Genomics (Unlisted, New York USA)
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Element Biosciences, Inc. (Unlisted, California USA)
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 BaseClear B.V. (Unlisted, Leiden Netherlands)
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Molecular Research LP (MR DNA) (Unlisted, Texas USA)
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Metagen (Unlisted, Gatton Australia)
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Centre Testing International Group (SZSE: 300012, Shenzhen China)
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Novogene Co., Ltd. (SSE: 688315, Beijing China)
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Berry Genomics Co., Ltd. (SZSE: 000710, Beijing China)
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 BGI Group (Unlisted, Shenzhen China)
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Beijing Biomarker Technologies Co., Ltd. (Unlisted, Beijing China)
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Guangzhou Magigene Biotechnology Co., Ltd. (Unlisted, Guangzhou China)
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Personal Biotechnology Co., Ltd. (Unlisted, Shanghai China)
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Soil Microbial DNA Testing Service market size?
The global Soil Microbial DNA Testing Service market is estimated at US$ 8.8 billion in 2025 (base year) and is projected to reach US$ 16.35 billion by 2032.
What growth rate is expected for the Soil Microbial DNA Testing Service market through 2032?
The market is expected to grow at a CAGR of 9.3% from 2026 to 2032, expanding from US$ 8.8 billion in 2025 to US$ 16.35 billion in 2032, roughly 1.9 times its base-year value.
How is Soil Microbial DNA Testing Service defined?
Soil microbial DNA testing service utilizes high-throughput sequencing and other molecular biology technologie to directly extract and analyze the genetic material (DNA) of microorganisms (bacteria, fungi, archaea, etc.) from soil. This allows for comprehensive identification of microbial community composition, diversity, and functional genes without the need for culturing.
How is the Soil Microbial DNA Testing Service market segmented by type?
By type, the market is segmented into Microbial Community Profiling, Metagenomic Sequencing, Targeted Quantitative Detection and Microbial Source Tracking Analysis.
What are the key applications of Soil Microbial DNA Testing Service?
Key applications covered include Precision Agriculture, Environmental Monitoring, Ecological Restoration, Biotechnology Research and Other.
Which companies are profiled in the Soil Microbial DNA Testing Service market report?
Key players profiled include Illumina, Inc. (NASDAQ: ILMN, California USA), SGS (SIX: SGSN, Geneva Switzerland), Thermo Fisher Scientific Inc. (NYSE: TMO, Massachusetts USA), Eurofins Scientific SE (Euronext: ERF, Luxembourg), Agilent Technologies, Inc. (NYSE: A, California USA), Zymo Research Corp. (Unlisted, California USA), Microsynth AG (Unlisted, Balgach Switzerland) and CD Genomics (Unlisted, New York USA), among 19 companies covered in total.
What geographies does the Soil Microbial DNA Testing Service market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
Who should buy the Soil Microbial DNA Testing Service market report?
The report is intended for manufacturers and solution providers, distributors and end users in Precision Agriculture, Environmental Monitoring and Ecological Restoration, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Soil Microbial DNA Testing Service market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from ‏3,500.00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.